90%Confidence
0Views
FDASource
2026-03-15Date
Summary
Vista Tears eye drops recalled due to lack of sterility assurance from Omni Lens, highlighting recurring cGMP violations at the manufacturer. This poses risks for the brand's dry eye relief segment and may trigger broader regulatory audits of the facility.
Actionable: Investigate the extent of Omni Lens's manufacturing issues and their impact on all distributed products under the Vista brand.
AI Confidence: 90%
Data Points
firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productVista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, Lubricant Drops, Sterile 10 ml (1/3 fl. oz.), Manuf
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now